Wanchoo departs Agfa for GE's PACS divisionGE Medical Systems late last month again demonstrated its commitment to PACS by luring digital image management veteran Vishal Wanchoo away from his position as vice president of marketing for Agfa
GE Medical Systems late last month again demonstrated its commitment to PACS by luring digital image management veteran Vishal Wanchoo away from his position as vice president of marketing for Agfa Medical. Although GEMS declined official comment, sources close to the Milwaukee company say that Wanchoo has been named general manager of GE's Integrated Imaging Solutions division and will report directly to GEMS president Jeffrey Immelt.
Anthony Lombardo, global general manager of IIS, will also shift positions. He reportedly has been tapped as general manager of IIS Americas sales and reports to Paul Mirabella, GE's vice president and general manager, Americas sales division.
Agfa has not yet named a replacement for Wanchoo, whose last day at the company was Nov. 21. In the meantime, senior marketing manager Bob Cooke will assume some of Wanchoo's responsibilities, with the rest divided among the Impax team at Agfa.
The loss of Wanchoo, who has assumed various roles in Agfa's PACS division since the early '90s, will surely be felt. He has been widely credited as one of the key architects in developing Agfa's strong market position.
The hiring of Wanchoo is a coup for GEMS, which has devoted substantial resources to its IIS division this year, especially with the acquisition of Lockheed Martin Medical Imaging Systems (PNN 5/97). Wanchoo's extensive marketing and engineering experience in PACS should prove invaluable to GEMS as it looks to grow its market share.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.